Fuminori Teraishi
- Biotechnology top 2%
- Cancer Research and Treatments 10
- Oncology top 5%
- Cancer-related Molecular Pathways 11
- Colorectal Cancer Surgical Treatments 9
- Genetics top 5%
- Virus-based gene therapy research 13
- Molecular Biology top 10%
- Cell death mechanisms and regulation 14
- RNA Interference and Gene Delivery 9
- Cancer Research top 10%
-
- Sarcoma Diagnosis and Treatment 6
-
- Gastrointestinal Tumor Research and Treatment 5
- Co-authors
- Jason J. DavisBingliang FangLidong ZhangToshiyoshi FujiwaraShuhong WuHongbo ZhuShunsuke KagawaNoriaki Tanaka
- Cited by
- BiotechnologyOncologyGenetics
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Fuminori Teraishi
64 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 93
- Biotechnology 320
- Oncology 615
- Genetics 495
- Molecular Biology 1.1k
- Cancer Research 232
Countries citing papers authored by Fuminori Teraishi
This map shows the geographic impact of Fuminori Teraishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuminori Teraishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuminori Teraishi more than expected).
Fields of papers citing papers by Fuminori Teraishi
This network shows the impact of papers produced by Fuminori Teraishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuminori Teraishi. The network helps show where Fuminori Teraishi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fuminori Teraishi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 19 | |
| 10 | 2020 | 5 | |
| 11 | 2018 | 48 | |
| 12 | 2013 | 0 | |
| 13 | 2010 | 4 | |
| 14 | 2006 | 10 | |
| 15 | 2006 | 34 | |
| 16 | 2006 | 20 | |
| 17 | 2005 | 29 | |
| 18 | 2005 | 30 | |
| 19 | 2004 | 84 | |
| 20 | 2004 | 30 |
About Fuminori Teraishi
Fuminori Teraishi is a scholar working on Microbiology, Oncology and Biotechnology, having authored 80 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (14 papers), Virus-based gene therapy research (13 papers), Cancer-related Molecular Pathways (11 papers), Cancer Research and Treatments (10 papers), RNA Interference and Gene Delivery (9 papers), Colorectal Cancer Surgical Treatments (9 papers), Sarcoma Diagnosis and Treatment (6 papers) and Gastrointestinal Tumor Research and Treatment (5 papers). The work is most often cited by research in Biotechnology (320 citations), Oncology (615 citations) and Genetics (495 citations). Fuminori Teraishi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Jason J. Davis, Bingliang Fang, Lidong Zhang, Toshiyoshi Fujiwara, Shuhong Wu, Hongbo Zhu, Shunsuke Kagawa, Noriaki Tanaka, Wei Guo and Satoru Kyo. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.